Arias-Stella reaction

Arias-Stella reaction is a histopathological term that refers to a change in the endometrial tissue, which is the inner lining of the uterus, in response to high levels of progesterone. This reaction is named after the Peruvian pathologist, Javier Arias-Stella, who first described it in 1954.

Overview

The Arias-Stella reaction is most commonly associated with pregnancy, but it can also occur in other conditions where there is an increase in progesterone levels, such as with the use of progesterone-containing contraceptives or in ectopic pregnancies. The reaction is characterized by the enlargement of the endometrial glands, with the cells becoming larger and the nuclei becoming more prominent. These changes can sometimes be mistaken for cancer, but they are benign and reversible.

Clinical Significance

The Arias-Stella reaction is important in the diagnosis of early pregnancy, as it can be seen in endometrial biopsies or curettage specimens obtained from women who are in the early stages of pregnancy. It can also be seen in women who have had a recent miscarriage or abortion. The reaction is also significant in the diagnosis of ectopic pregnancy, as it can be seen in the endometrial tissue even when the pregnancy is located outside the uterus.

Diagnosis

The diagnosis of the Arias-Stella reaction is made by a pathologist, who examines the endometrial tissue under a microscope. The characteristic changes in the cells and glands of the endometrium are usually sufficient to make the diagnosis. However, in some cases, additional tests may be needed to rule out other conditions, such as cancer.

Treatment

As the Arias-Stella reaction is a normal response to high levels of progesterone, no specific treatment is needed. The changes in the endometrium will reverse once the levels of progesterone decrease.

See Also

• Endometrium
• Progesterone
• Ectopic pregnancy
• Early pregnancy

Arias-Stella reaction Resources
Need Help Finding a Doctor? WikiMD's DocFinder can help find general and specialist physicians.	Latest articles Most recent articles Ongoing trials.